Cheng Sohanya Roshan 4
4 · Carisma Therapeutics Inc. · Filed Nov 1, 2024
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-31+38,700→ 38,700 totalExercise: $0.97Exp: 2034-10-31→ Common Stock (38,700 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over three years in equal monthly installments following October 31, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.